Keyphrases
Dystrophin
100%
Duchenne muscular Dystrophy
100%
Natural History
100%
T Cell Immune Response
100%
Exon Skipping
37%
Epitope
37%
Clinical Trials
25%
Immune Response
25%
First Year
12%
Exon
12%
Exondys 51
12%
Antisense Oligonucleotides
12%
Clinical Development
12%
T Cells
12%
Natural History Study
12%
Non-ambulant
12%
Gene Therapy
12%
Therapy Approaches
12%
RNA-based
12%
Exon 53
12%
Inflammatory Infiltrate
12%
Untreated Patients
12%
Ambulation Status
12%
Immunological Response
12%
Immune Cells
12%
Interferon-gamma Release Assay
12%
Revertant Fibres
12%
Correlated Data
12%
ELISpot Assay
12%
T Cell Activation
12%
Epitope Peptide
12%
Inflammatory Cascade
12%
ELISPOT
12%
Clinical Centers
12%
Cell Manufacturing
12%
Viral
12%
Immunology and Microbiology
T Cell
100%
Dystrophin
100%
Adoptive Immunity
100%
Epitope
50%
Exon Skipping
37%
Immune Response
25%
Exon
25%
Immunocompetent Cell
12%
Cell Activity
12%
Enzyme-Linked Immunospot Assay
12%
Revertant
12%
Antisense
12%
ELISPOT
12%
Biochemistry, Genetics and Molecular Biology
Dystrophin
100%
T Cell
100%
Cellular Immunity
100%
Exon Skipping
37%
Exon
25%
Clinical Trial
25%
Immune Response
25%
Oligonucleotide
12%
RNA
12%
Antisense
12%
Revertant
12%
Immunocompetent Cell
12%
Gene Therapy
12%
Cell Activity
12%
Neuroscience
Muscular Dystrophy
100%
Dystrophin
100%
T Cell
100%
Epitope
50%
Exon Skipping
37%
Exon
25%
Antisense Oligonucleotide
12%
Cell Activity
12%